CD137 (4-1BB) and T-Lymphocyte Exhaustion

Paula Molero-Glez,Arantza Azpilikueta,Laura Mosteo,Javier Glez-Vaz,Belen Palencia,Ignacio Melero

DOI: https://doi.org/10.1158/1078-0432.CCR-24-1568

2024-09-13

Abstract:CD137 (4-1BB) costimulation results in the potent activation of antitumor T lymphocytes and elicits antitumor efficacy that is synergistic with anti-PD(L)1 checkpoint inhibitors, especially when using bispecific constructs. Emerging experimental evidence indicates that 4-1BB ligation prevents and may revert T-cell exhaustion. See related article by Jeon et al., p. 4155.